Picture of PPD logo

PPD — PPD Share Price

0.000.00%
Last trade - 00:00
HealthcareAdventurousLarge Cap

Momentum

Relative Strength (%)
1m+5.46%
3m+4.65%
6m-0.92%
1yr+12.67%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)25.54
PEG Ratio (f)2.02
EPS Growth (f)14.47%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Valuen/a
Price to Tang. Bookn/a
Price to Free Cashflow38.27
Price to Sales2.83
EV to EBITDA20.89

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital15.22%
Return on Equityn/a
Operating Margin10.95%

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total Revenue$m2,679.573,001.053,748.974,031.024,681.476,008.176,410.5314.97%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/a+47.17-58-55.83+248.63+172.69+14.47n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of PPD EPS forecast chart

Profile Summary

PPD, Inc. is a provider of drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The Company operates through two segments: Clinical Development Services and Laboratory Services. The Clinical Development Services segment provides a range of services to its customers including early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment provides services to its customers including bioanalytical, vaccine sciences, good manufacturing practice (GMP), central lab and biomarker testing.

Directors

    Last Annual
    December 31st, 2020
    Last Interim
    September 30th, 2021
    Incorporated
    January 1st, 1970
    Public Since
    January 1st, 1970
    No. of Shareholders
    60
    No. of Employees
    26,000
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Global Select Market
    Shares in Issue
    351,394,547

    PPD Share Price Performance

    Latest News for PPD

    Upcoming Events for PPD

    Q4 2021 PPD Inc Earnings Release

    PPD Inc Annual Shareholders Meeting

    Q1 2022 PPD Inc Earnings Release

    Similar to PPD

    Picture of 2Seventy Bio logo

    2Seventy Bio

    us flag iconNASDAQ Global Select Market

    Picture of 4D Molecular Therapeutics logo

    4D Molecular Therapeutics

    us flag iconNASDAQ Global Select Market

    Picture of AbCellera Biologics logo

    AbCellera Biologics

    us flag iconNASDAQ Global Select Market

    Picture of AbSci logo

    AbSci

    us flag iconNASDAQ Global Select Market

    Picture of ACADIA Pharmaceuticals logo

    ACADIA Pharmaceuticals

    us flag iconNASDAQ Global Select Market

    FAQ

    Or unlock with your email

    Or unlock with your email